In response to the speech by Dr Vincent Wijeysingha where he claimed that a major corporation had bullied Jolovan Wham from the Humanitarian Organization for Migrant Economics (HOME) into silence, Bridget Tan the founder and president HOME has issued this statement:

"That is not quite correct – I have told Jolovan Wham not to speak at the event because he is the Executive Director (ED) and HOME is not a political party or association. He has become a public figure because of his work with HOME, hence even if he speaks in his personal capacity, what he says may affect the public's perception of HOME.
 
Indeed there was a feedback of concern from a corporate sponsor, however my advice to Jolovan is independent of external parties. I am responsible to our board and have acted in the interest of our beneficiaries such as migrant men and women workers availing of our shelter services and educational programmes."
You May Also Like

美国医护人员接种辉瑞疫苗 出现严重过敏反应

据《纽约时报》报导,美国阿拉斯加州有医疗前线人员,接种辉瑞(Pfizer)与BioNTech的冠病疫苗,10分钟后即出现严重过敏,脸部和身上出现皮疹、心跳加速和呼吸急促等症状。 《纽时》报导这名来自巴莱特(Bartlett)地区医院的医护人员,是在本周二(15日)接种,但10分钟后即出现过敏迹象。该医院急诊部主任Lindy Jones,则指出上述医护人员此前还接受了标准国民治疗,但症状反复,被送入加护病房观察。 原本打算让该医护人员在16日傍晚出院,不过仍决定让她继续留医。 还有第二名医护人员在周三注射疫苗,不过10分钟后也出现眼部浮肿、头晕和嗓子发痒症状。随即他被送入急救室注射肾上腺素和接受药物治疗,不过,院方解释这名人员并不是过敏,且一小时后可出院。 美国监管机构在发布紧急批准时,曾同时提醒民众,若对疫苗内成分有已知过敏反应者,应避免接种。 至于疫苗生产商辉瑞表示,尚未接到来自阿拉斯加严重过敏病例报告的细节,不过会积极与当地卫生机构合作以进行评估。 《纽约时报》指出,虽然辉瑞疫苗临床试验有4.4万人参与,有效率达到了95%,但阿拉斯加州出现的情况会加剧对疫苗副作用的担忧。 新加坡采购辉瑞疫苗 新加坡总理李显龙在本月14日傍晚,曾揭露政府拨款超过10亿元,以采购冠病19疫苗。所有公民和长期居住在本地的居民,都能免费接种冠病疫苗。 卫生科学局则批准辉瑞研发的冠病疫苗,预计月底就会抵达我国,相信将使我国成为全球率先获得疫苗的国家之一。 新加坡卫生部设立的冠病疫苗专家团早前称,辉瑞疫苗成效高达95%,其安全性与其他注册疫苗基本一致。…

Bridge gap in social memory with PIDB: NSP

The following is a press release from the National Solidarity Party on…

Celebrate National Day – but is this necessary?

At S$3,300 for each billboard, are town councils spending unnecessarily?

MP Hri Kumar’s response to Siew Kum Hong

The following article first appeared in Siew Kum Kong’s blog. Siew Kum…